Program Tablets 409.8mg 409.8 mg Tablet is a Health Canada–registered veterinary drug (DIN 02087367) held by Novartis Animal Health Canada Inc, containing Lufenuron. Health Canada lists its status as Cancelled Post Market (status date 22 Jun 2000). Nexara Health has matched 4 registrations of Lufenuron across 1 other regulated market.
Health Canada registration
| DIN | 02087367 |
|---|---|
| Brand name | Program Tablets 409.8mg |
| Active ingredient | Lufenuron |
| Strength | 409.8 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Novartis Animal Health Canada Inc |
| Status | Cancelled Post Market — 22 Jun 2000 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Lufenuron registered in other markets
4 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Lufenuron | Lonza AG | Powder | FDA NDC | ||
| United States | Lufenuron | Hubei Honch Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Lufenuron | Laurus Synthesis Pvt Ltd | Powder | FDA NDC | ||
| United States | Lufenuron | Alivira Animal Health Limited | Powder | FDA NDC |
See every manufacturer of Lufenuron worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Program Tablets 409.8mg (DIN 02087367) marketed in Canada?
No. Health Canada lists DIN 02087367 as Cancelled Post Market as of 22 Jun 2000.
Who holds the Canadian licence for this product?
Novartis Animal Health Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Lufenuron registered outside Canada?
Yes — Nexara Health has matched 4 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02087367, status date 2000-06-22; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02087367, status date 2000-06-22; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02087367, status date 2000-06-22; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.